Categories LATEST
Intel Q3 2024 Earnings: Stay tuned for the live earnings call and real-time transcript
Intel Corporation (NASDAQ: INTC) will be reporting third-quarter 2024 results today after the bell. It is estimated that the chipmaker incurred a loss in Q3, on an adjusted basis.
Listen to Intel’s earnings call live and check the real-time transcript
Wall Street is looking for a loss of $0.02 per share for Q3, on an adjusted basis, compared to earnings of $0.37 per share in the year-ago quarter. The consensus revenue estimate for the September quarter is $13.02 billion.
In the second quarter, Intel’s revenues edged down 1% year-over-year to $12.8 billion. Revenues of Client Computing, the company’s main operating segment, grew 9%, which was more than offset by weakness in the other divisions. It reported earnings of $0.02 per share for the June quarter, excluding special items, down 85% from the prior-year period.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report
Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,
J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights
The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs
